Definium Therapeutics, Inc. · NASDAQ:DFTX

Definium Therapeutics, Inc. insider trades

Definium Therapeutics, Inc.'s insiders made 0 buys and 11 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

DateInsiderTradeSharesPriceFiling
Sep 25, 2026Karlin DanielSale10,853US$37Form 4
Sep 25, 2026Barrow RobertSale31,550US$37Form 4
Sep 25, 2026Wiley Matthew T.Sale3,097US$37Form 4
Sep 25, 2026Sullivan MarkSale14,051US$37Form 4
Sep 25, 2026Roberts BrandiSale3,377US$37Form 4
Sep 3, 2026Barrow RobertSale19,023US$38Form 4
Jun 25, 2026Sullivan MarkSale13,008US$45Form 4
Jun 25, 2026Karlin DanielSale10,035US$45Form 4
Jun 25, 2026Roberts BrandiSale3,013US$45Form 4
Jun 25, 2026Barrow RobertSale29,208US$45Form 4

Definium Therapeutics, Inc. shareholders